Sinovent
company
About
Sinovent is engaged in the technical development, consulting, and services of biological medicines.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- ¥1B
- Industries
- Biotechnology,Life Science
- Founded date
- Jan 1, 2017
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Founded in 2016, Sinovent is a global biopharmaceutical company focused on innovation. Sinovent is centered around global standard excellence through its advanced biotechnology platform, decades of management experience, as well as financial support. Sinovent uniquely combines its expertise in science, management and finance, to develop and promote advanced treatment methods to solve worldwide healthcare problems. Currently, the company has 12 products in development, primarily in oncology, auto-immune diseases, and infectious diseases.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥1B
Sinovent has raised a total of
¥1B
in funding over 2 rounds. Their latest funding was raised on
Aug 25, 2020 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 25, 2020 | Series C | ¥1B | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Sinovent is funded by 1 investors.
Huaxu Investment
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
